News
Eutelsat Group Achieves Platinum Score in Space Sustainability Rating
Eutelsat Group (ISIN: FR0010221234 - Euronext Paris / London Stock Exchange: ETL), has announced that its first generation of more than 600 satellites in Low Earth Orbit (LEO) has achieved a
GenSight Biologics Appoints William Monteith to its Board of Directors
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible) (Paris:SIGHT), a biopharma company focused on developing and commercializing innovative gene therapies
Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
Median Technologies to Participate in the 2024 ASCO Annual Meeting, May 31 - June 4, 2024, McCormick Place, Chicago, IL, USA
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, “Median” or “The Company”) announced today that the Company will be participating in the 2024 American Society
Lexicon Pharmaceuticals Selects Medidata to Help Advance First Non-Opioid Drug for Neuropathic Pain in Over Two Decades
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, announced today that it has been selected by Lexicon Pharmaceuticals, Inc. to
Pernod Ricard Partners With EcoSPIRITS for Global Expansion of Circular Spirits Distribution
Regulatory News:
Press Release – Paris, 28 May 2024
Pernod Ricard (Paris:RI) and ecoSPIRITS today announce entering a new stage in their relationship with a five-year global licensing
Sensorion Announces its Participation in Upcoming Investor Conferences in June 2024
Regulatory News:
Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and
FOCUS ENTERTAINMENT: PulluP Entertainment successfully completes its capital increase with a priority period and total gross amount of €23.08m after full exercise of the extension clause and th
Yahsat Partners With Eutelsat Group to Leverage EUTELSAT KONNECT Satellite to Drive Growth Across Its Global Footprint
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240522761453/en/
Eutelsat Group (ISIN: FR0010221234 - Euronext Paris
Median Technologies, a World Leading Oncology Clinical Trial Imaging Services Provider, Becomes Preferred Vendor to Another Top 3 Pharmaceutical Company
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, “Median” or “The Company”) (Paris:ALMDT) announced today that the Company has been selected as preferred
Freelance.com: 1 st quarter 2024 revenue: €258.2m (+24%)
Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast
Kaufman & Broad SA: VOTING RESULTS OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF 6 MAY 2024
Poxel Reports Revenue for the First Quarter 2024 and Provides Corporate Update
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
Pernod Ricard’s Net-zero Science-based Targets in Line with a 1.5°C Trajectory Approved by the Science Based Targets initiative (SBTi)
Regulatory News:
Pernod Ricard (Paris:RI):
Press release – Paris, May 16th 2024
Pernod Ricard announces today that its near- and long-term science-based GHG emissions reduction targets in
Vochlea Music entscheidet sich für Verimatrix XTD
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von Sicherheit für die moderne vernetzte Welt, gab heute bekannt, dass sich das britische Unternehmen Vochlea Music für Verimatrix XTD
FOCUS ENTERTAINMENT: PulluP Entertainment is launching a capital increase by way of a public offering with a priority period, on an irreducible basis only, for the benefit of shareholders, for an init
Vochlea Music Selects Verimatrix XTD
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that UK-based Vochlea Music chose Verimatrix
BILENDI: Q1 2024 revenues up +4.6% at €14.5 million
Medidata Selected by Worldwide Clinical Trials to Accelerate Trials and Transform Patient Experience
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced an expansion of its relationship with Worldwide Clinical Trials
Verimatrix XTD Enterprise Suite triumphiert bei 2024 Cybersecurity Excellence Awards
Verimatrix, (Paris:VMX) (Euronext Paris: VMX), ein führender Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, teilte heute mit, dass seine Verimatrix XTD
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
GenSight Biologics: Annual General Meeting on May 29, 2024
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal
Verimatrix XTD Enterprise Suite Triumphs at 2024 Cybersecurity Excellence Awards
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that its Verimatrix XTD